Aspiriant LLC’s Schwab Emerging Markets Equity ETF SCHE Stock Holding History
Bought
Maintained
Sold
Other funds holding SCHE
CSIA
MG
HC
Aspiriant LLC's SCHE Position: Q3 2021 in Review
Aspiriant LLC sold out of Schwab Emerging Markets Equity ETF (SCHE) in Q3 2021, closing a stake of 6,133 shares — an estimated $201K sold.
Aspiriant LLC first reported a position in SCHE in Q1 2016 and held it in 21 quarters. The position peaked at $3.09M in Q3 2016. 677 funds tracked by Wall St. Rank hold SCHE as of Q3 2021.
- Aspiriant LLC reported no remaining Schwab Emerging Markets Equity ETF position as of Q3 2021 after selling out during the quarter.
- Aspiriant LLC sold 6,133 Schwab Emerging Markets Equity ETF shares in Q3 2021, an estimated $201K.
- Aspiriant LLC first reported a position in Schwab Emerging Markets Equity ETF in Q1 2016 and held it in 21 quarters.
- Aspiriant LLC's Schwab Emerging Markets Equity ETF position peaked at $3.09M in Q3 2016.
- 677 funds tracked by Wall St. Rank held Schwab Emerging Markets Equity ETF as of Q3 2021.
Based on Aspiriant LLC's 13F filing for Q3 2021, filed 27 Oct 2021.